Pro-inflammatory immune pathways and dendritic cell differentiation

Pro-inflammatory immune pathways and dendritic cell (DC) differentiation represent the integrated biological processes that govern the transition of immature DCs into potent antigen-presenting cells capable of initiating adaptive immunity. Dendritic cells act as essential bridges between innate and adaptive immune systems, capturing antigens and maturing in response to pro-inflammatory stimuli such as Toll-like receptor (TLR) ligands or cytokines like TNF-alpha and IL-6 (Worbs et al., 2017, Nature Reviews Immunology). This maturation process involves the upregulation of MHC class II and co-stimulatory molecules like CD80 and CD86, which are critical for the activation of T-cell responses. Dysregulation of these pathways is a hallmark of autoimmune and chronic inflammatory diseases, where overactive DCs drive pathological self-reactivity (Banchereau et al., 2000, Nature). Conversely, the suppression of DC differentiation within the tumor microenvironment is a key mechanism of cancer immune evasion. While this term describes a broad biological process rather than a single molecular entity, it encompasses numerous high-value therapeutic targets, including JAK kinases and various cytokine receptors, which are targeted to modulate immune activity in clinical settings.

Other names

Dendritic cell maturation pathwaysInflammatory signaling in antigen-presenting cellsDC differentiation and activation cascades

Modulation of dendritic cell maturation and inflammatory signaling through the inhibition of specific cytokines or intracellular signaling transducers like JAK kinases and NF-κB.